BMRN

8:06 am Biomarin Pharm announces selection of NAGLU fusion protein drug development candidate BMN 250 for the treatment of Sanfilippo B (MPS IIIB)

moreView todays social media effects on BMRNView the latest stocks trending across Twitter. Click to view dashboardSee who BioMarin is hiring next, click here to view […]

BioMarin Announces Selection of NAGLU Fusion Protein Drug Development Candidate BMN 250 for the Treatment of Sanfilippo B (MPS IIIB)

[GlobeNewswire] – Potential to Add Fourth MPS Treatment to BioMarin Franchise moreView todays social media effects on BMRNView the latest stocks trending across Twitter. Click to view dashboardSee who BioMarin is hiring next, click here to view […]

BioMarin Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

[at noodls] – SAN RAFAEL, Calif., April 18, 2013 (GLOBE NEWSWIRE) — BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that on April 15, 2013, the compensation committee of BioMarin’s board of directors approved … moreView todays social media effects on BMRNView the latest stocks trending across Twitter. Click to view dashboardSee who BioMarin is hiring next, click here to view […]

BioMarin to Host First Quarter 2013 Financial Results Conference Call and Webcast on Thursday, April 25 at 5:00 p.m. ET

[at noodls] – SAN RAFAEL, Calif., April 4, 2013 (GLOBE NEWSWIRE) — BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Jean-Jacques Bienaimé, Chief Executive Officer of BioMarin, will host a conference … moreView todays social media effects on BMRNView the latest stocks trending across Twitter. Click to view dashboardSee who BioMarin is hiring next, click here to view […]

BioMarin Completes Additional Partial Exchange of Convertible Notes Due 2017 for Common Stock

[at noodls] – SAN RAFAEL, Calif., March 25, 2013 (GLOBE NEWSWIRE) — BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) announced today that an additional six holders of its 1.875% Convertible Senior Subordinated Notes due … moreView todays social media effects on BMRNView the latest stocks trending across Twitter. Click to view dashboardSee who BioMarin is hiring next, click here to view […]

PropThink: Catalyst Licenses New Candidate Ahead of November Data Release

[ACN Newswire] – By Jake KingCatalyst Pharmaceutical Partners (NASDAQ:CPRX) climbed as much as 18% ahead of the bell Wednesday after the company announced that it licensed the rights to an orphan drug for Lambert-Eaton … moreView todays social media effects on BMRNView the latest stocks trending across Twitter. Click to view dashboard […]

BioMarin to Host Third Quarter 2012 Financial Results Conference Call and Webcast on Thursday, October 25 at 5:00 p.m. ET

[at noodls] – BioMarin to Host Third Quarter 2012 Financial Results Conference Call and Webcast on Thursday, October 25 at 5:00 p.m. ET NOVATO, Calif., Oct. 4, 2012 (GLOBE NEWSWIRE) — BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) … moreView todays social media effects on BMRNView the latest stocks trending across Twitter. Click to view dashboard […]